Truveta provides a comprehensive healthcare data platform that offers insights into patient care through real-time data analytics, primarily to healthcare and life science organizations.
truveta.comLinkedInBellevue, Wash.
2 sources
The article says the investment came from 17 health systems but names only Illumina and Regeneron; the 17 unnamed systems are not individually listed.; not on the page it cites, so not applied: date
Published by hand (truveta.com): "To make this bold initiative possible, 17 health systems, Illumina, and Regeneron have invested $320M in Truveta preferred equity at a valuation exceeding $1B.": brand backfill hand check: Truveta's announcement states the $320M preferred equity investment at a valuation exceeding $1B
2 sources
Source 2 was published July 12, but explicitly dates the Series A to July 13, 2021; the company's July 13 release supports that announcement date. No source states a lead investor, financing total, valuation, or headquarters.
Published by hand (truveta.com): "Truveta is uniquely founded and governed by its members, who also have invested $95 million in the company, closing out Series A funding.": brand backfill hand check: the page states the round (announced)
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $320M at $1 billion valuation | 2025-01-13 | not stated | No recent discussion |
2 sources [ VERIFIED · CORRECTED ] read against 1 of 2 sources
The article says the investment came from 17 health systems but names only Illumina and Regeneron; the 17 unnamed systems are not individually listed.; not on the page it cites, so not applied: date Published by hand (truveta.com): "To make this bold initiative possible, 17 health systems, Illumina, and Regeneron have invested $320M in Truveta preferred equity at a valuation exceeding $1B.": brand backfill hand check: Truveta's announcement states the $320M preferred equity investment at a valuation exceeding $1B | ||||
| Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $95M | 2021-07-13 | not stated | No recent discussion |
2 sources [ VERIFIED · CORRECTED ] read against 2 sources
Source 2 was published July 12, but explicitly dates the Series A to July 13, 2021; the company's July 13 release supports that announcement date. No source states a lead investor, financing total, valuation, or headquarters. Published by hand (truveta.com): "Truveta is uniquely founded and governed by its members, who also have invested $95 million in the company, closing out Series A funding.": brand backfill hand check: the page states the round (announced) [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]2 pages read: truveta.com, marketscreener.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 2 sources·[ BRANDING ]logo and colour from the homepage | ||||